Literature DB >> 21282426

Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.

J Chase McNeil1, Kristina G Hulten, Sheldon L Kaplan, Edward O Mason.   

Abstract

Staphylococcus aureus resistance to mupirocin is often caused by acquisition of a novel isoleucyl-tRNA synthetase encoded on the plasmid gene mupA. We tested S. aureus isolates from children at Texas Children's Hospital with recurrent skin and soft tissue infections for mupirocin resistance and mupA. Of 136 isolates, 20 were resistant to mupirocin (14.7%). Fifteen isolates (11%) carried mupA, and the gene was more common in methicillin-susceptible S. aureus (21.4%) than methicillin-resistant S. aureus (8.3%; P=0.03). Seven of 20 mupirocin-resistant isolates displayed clindamycin resistance.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21282426      PMCID： PMC3088235          DOI： 10.1128/AAC.01587-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  Molecular characterization of resistance to mupirocin in methicillin-susceptible and -resistant isolates of Staphylococcus aureus from nasal samples.

Authors:  Fernando Chaves; Jesus García-Martínez; Sonia de Miguel; Joaquín R Otero
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Mupirocin resistance related to increasing mupirocin use in clinical isolates of methicillin-resistant Staphylococcus aureus in a pediatric population.

Authors:  Jacob S Hogue; Patricia Buttke; LoRanee E Braun; Mary P Fairchok
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

3.  Mutations affecting the Rossman fold of isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus.

Authors:  Martin Antonio; Neil McFerran; Mark J Pallen
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

4.  Three-year surveillance of community-acquired Staphylococcus aureus infections in children.

Authors:  Sheldon L Kaplan; Kristina G Hulten; Blanca E Gonzalez; Wendy A Hammerman; Linda Lamberth; James Versalovic; Edward O Mason
Journal:  Clin Infect Dis       Date:  2005-05-06       Impact factor: 9.079

5.  Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates.

Authors:  M A Ramsey; S F Bradley; C A Kauffman; T M Morton
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

6.  Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance.

Authors:  A Upton; S Lang; H Heffernan
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

7.  Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men.

Authors:  Binh An Diep; Henry F Chambers; Christopher J Graber; John D Szumowski; Loren G Miller; Linda L Han; Jason H Chen; Felice Lin; Jessica Lin; Tiffany HaiVan Phan; Heather A Carleton; Linda K McDougal; Fred C Tenover; Daniel E Cohen; Kenneth H Mayer; George F Sensabaugh; Françoise Perdreau-Remington
Journal:  Ann Intern Med       Date:  2008-01-30       Impact factor: 25.391

8.  High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases.

Authors:  J Gilbart; C R Perry; B Slocombe
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

9.  Biochemical basis of mupirocin resistance in strains of Staphylococcus aureus.

Authors:  T H Farmer; J Gilbart; S W Elson
Journal:  J Antimicrob Chemother       Date:  1992-11       Impact factor: 5.790

10.  Molecular characterization of the gene encoding high-level mupirocin resistance in Staphylococcus aureus J2870.

Authors:  J E Hodgson; S P Curnock; K G Dyke; R Morris; D R Sylvester; M S Gross
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191
View more
  25 in total

Review 1.  Prevention of Recurrent Staphylococcal Skin Infections.

Authors:  C Buddy Creech; Duha N Al-Zubeidi; Stephanie A Fritz
Journal:  Infect Dis Clin North Am       Date:  2015-09       Impact factor: 5.982

Review 2.  The Growing Threat of Antibiotic Resistance in Children.

Authors:  Rachel L Medernach; Latania K Logan
Journal:  Infect Dis Clin North Am       Date:  2018-03       Impact factor: 5.982

3.  High prevalence of mupirocin resistance in Staphylococcus aureus isolates from a pediatric population.

Authors:  Nina K Antonov; Maria C Garzon; Kimberly D Morel; Susan Whittier; Paul J Planet; Christine T Lauren
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

4.  Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children.

Authors:  J Chase McNeil; Kristina G Hulten; Sheldon L Kaplan; Edward O Mason
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

5.  Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections.

Authors:  Stephanie A Fritz; Patrick G Hogan; Bernard C Camins; Ali J Ainsworth; Carol Patrick; Madeline S Martin; Melissa J Krauss; Marcela Rodriguez; Carey-Ann D Burnham
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

6.  Use of Corynebacterium pseudodiphtheriticum for elimination of Staphylococcus aureus from the nasal cavity in volunteers exposed to abnormal microclimate and altered gaseous environment.

Authors:  N V Kiryukhina; V G Melnikov; A V Suvorov; Yu A Morozova; V K Ilyin
Journal:  Probiotics Antimicrob Proteins       Date:  2013-12       Impact factor: 4.609

7.  Emergence of a Staphylococcus aureus Clone Resistant to Mupirocin and Fusidic Acid Carrying Exotoxin Genes and Causing Mainly Skin Infections.

Authors:  Anastassios Doudoulakakis; Iris Spiliopoulou; Nikolaos Spyridis; Nikolaos Giormezis; John Kopsidas; Maria Militsopoulou; Evangelia Lebessi; Maria Tsolia
Journal:  J Clin Microbiol       Date:  2017-06-07       Impact factor: 5.948

8.  Repurposing auranofin for the treatment of cutaneous staphylococcal infections.

Authors:  Shankar Thangamani; Haroon Mohammad; Mostafa F N Abushahba; Tiago J P Sobreira; Mohamed N Seleem
Journal:  Int J Antimicrob Agents       Date:  2016-01-23       Impact factor: 5.283

9.  Nasal carriage of multi-drug resistant Panton-Valentine leucocidin-positive methicillin-resistant Staphylococcus aureus in children in Tripoli-Libya.

Authors:  Omaima H Al-haddad; Abdulaziz Zorgani; Khalifa Sifaw Ghenghesh
Journal:  Am J Trop Med Hyg       Date:  2014-02-03       Impact factor: 2.345

10.  Preventing surgical site infections: a randomized, open-label trial of nasal mupirocin ointment and nasal povidone-iodine solution.

Authors:  Michael Phillips; Andrew Rosenberg; Bo Shopsin; Germaine Cuff; Faith Skeete; Alycia Foti; Kandy Kraemer; Kenneth Inglima; Robert Press; Joseph Bosco
Journal:  Infect Control Hosp Epidemiol       Date:  2014-05-21       Impact factor: 3.254
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.